A decades-old malaria drug touted by President Donald Trump as a potential coronavirus treatment has failed to impress in an early-stage study.
The study, performed in China, followed 30 patients with mild symptoms. It investigated hydroxychloroquine, a cousin of chloroquine. Both can treat malaria, lupus and rheumatoid arthritis. In recent days, Trump has reiterated his positive views on their potential in coronavirus treatment.
But the drug didn’t pan out in the study, Evercore ISI analyst Umer Raffat said in a note to clients. He described the results as “far from positive.” Of three key measures, just one favored the use of the malaria drugs in coronavirus treatment…
To read thee entire article from Investor’s Business Daily, click https://www.investors.com/news/technology/coronavirus-treatment-trump-touted-malaria-drug-fails-to-impress/
Everyone…EVERYONE needs to listen to Dr. Fauci and only Dr. Fauci. He has the knowledge, the experience and the ability to present the FACTS so EVERYONE who cares to be informed by FACTS will be.